Evaluating and mitigating bias in machine learning models for cardiovascular disease prediction
Fuchen Li1, Patrick Wu2, Henry H Ong2
1College of Art and Science, Vanderbilt University, Nashville, TN, USA.
Journal of Biomedical Informatics
|January 27, 2023
Summary
Machine learning models for cardiovascular disease risk show bias, particularly against women. While some debiasing methods help gender disparities, they don't fix race bias and can reduce accuracy.
Area of Science:
- Cardiovascular disease risk prediction
- Machine learning in healthcare
- Health equity and bias analysis
Background:
- Systematic bias in health data can compromise the performance of machine learning (ML) models for cardiovascular disease (CVD) risk assessment.
- Ensuring equitable performance across demographic groups is crucial for reliable CVD risk prediction.
- Investigating bias in ML models and evaluating debiasing strategies is essential for fair healthcare applications.
Purpose of the Study:
- To evaluate the performance equivalence of ML-based CVD risk prediction models across different demographic groups (race and gender).
- To assess the effectiveness of bias mitigation methods in reducing disparities within these ML models.
- To compare the fairness of ML models against a traditional baseline model, the AHA Pooled Cohort Risk Equations (PCEs).
Main Methods:
- Utilized de-identified Electronic Health Records (EHR) data from Vanderbilt University Medical Center.
- Applied various ML algorithms (logistic regression, random forest, gradient-boosting trees, LSTM) to develop predictive models.
- Assessed model bias and fairness using Equal Opportunity Difference (EOD) and Disparate Impact (DI), comparing ML models with AHA PCEs and testing three debiasing techniques.
Main Results:
- Most ML models demonstrated lower bias (EOD, DI) compared to AHA PCEs across race groups.
- Significant bias was observed across gender groups for both ML models and AHA PCEs.
- Resampling by case proportion effectively reduced gender-based bias but showed limited impact on race-based bias and sometimes decreased model accuracy.
Conclusions:
- Both traditional and ML-based CVD risk prediction models exhibit bias against women, highlighting the need for targeted interventions.
- Bias mitigation strategies, particularly resampling by proportion, show promise for addressing gender disparities in CVD risk prediction.
- Further research is needed to develop effective debiasing methods that do not compromise predictive accuracy and address all demographic groups equitably.
Related Concept Videos
Bias in Epidemiological Studies
481
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
481
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
226
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
226
Errors occurring during blood pressure monitoring
820
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
820
Assessment of the Cardiovascular System I: Subjective Data
400
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
400
Coronary Artery Disease IV: Preventive Measures
30
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
30


